Sponsors

Introducing Omicron-reactive antibodies

The Omicron variant of the SARS-CoV-2 virus possesses multiple mutations in the spike protein. However, this variant also has mutations in the nucleocapsid protein (N).

This is critically important as current antigen tests detect the nucleocapsid by immunoassay. The antibodies employed in these tests must recognise the mutated N antigen otherwise a false-negative test will result.

ViroStat has validated its four best monoclonal antibody pairs (products #3865-#3868) for reactivity with the nucleocapsid of the Omicron variant. These high-affinity antibody pairs are used successfully in lateral flow and ELISA applications for antigen detection of the other variants as well.

Download the updated data sheet for these antibodies from the ViroStat website.

www.virostat-inc.com

Latest Issues

The Festival of Genomics and Biodata

ExCeL, London Docklands,
29-30 January 2025

Microbiology Society Annual Conference 2025

Liverpool Arena and Convention Centre
31 March - 3 April, 2025

BSMT Annual Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Ghent Pathology 2025

ICC Ghent, Belgium
24-26 June, 2025

37th European Congress of Pathology

ACV, Vienna, Austria
6 -10 September, 2025